Analyst Reco. Virbac

Equities

Real-time Euronext Paris Other stock markets 05:55:35 2026-05-18 am EDT			5-day change	1st Jan Change
346.00 ^EUR	-1.14%		-1.70%	-3.22%

May. 11	Virbac continues decline despite positive recommendation
Apr. 17	Virbac: 2026 starts on strong footing

May. 11	Virbac continues decline despite positive recommendation
Apr. 17	Virbac: 2026 starts on strong footing
Mar. 19	Stifel sees Virbac as undervalued, sets 440 euro price target
Mar. 18	Virbac in the green following results and outlook
Jan. 20	Virbac beats 2025 targets, lifts 2026 outlook
Jan. 20	Stifel Raises Price Target on Virbac
Jan. 20	Virbac Significantly Outperforms the Market with Annual Revenues and 2026 Targets
25-10-17	Virbac: Q3 crushed doubts about execution ability
25-09-15	Virbac: Oddo BHF remains positive despite H1 results
25-07-17	Virbac: A healthy Q2 impresses the markets
25-07-03	Oddo BHF Upgrades Virbac to Outperform, Boosts PT	MT
25-07-03	Virbac: Oddo BHF upgrades stock
25-04-17	Virbac: brokers' advice following quarterly results
25-04-16	Virbac: Stifel remains bullish after quarterly results
25-04-16	Virbac: Decent Q1; Clarity on US tariff exposure was a key takeaway
25-04-16	Virbac: Stifel still buying after Q1 results
25-03-17	Virbac: Oddo BHF remains 'neutral', confirms its target
25-03-17	Virbac: 2024 profitability somewhat exceeded expectations; stock re-rating underway
25-03-17	Virbac: Stifel raises its recommendation
25-01-17	Virbac: 2024 top-line goals met; uninspiring 2025 outlook could be raised later
25-01-17	Oddo BHF Downgrades Virbac to Neutral, Cuts PT	MT
24-11-04	Virbac: Stifel lowers its target price for the stock
24-10-18	Virbac: Market’s anxiety over the Q3 miss was not warranted
24-10-01	Virbac: Making good strides
24-09-19	Virbac: Stifel raises its target price